P21 Rekombinanter Antikörper
P21 Rekombinant Antikörper für WB, IF/ICC, IP, ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
WB, IF/ICC, IP, ELISA
Konjugation
Unkonjugiert
CloneNo.
3N14
Kat-Nr. : 82669-2-RR
Synonyme
Geprüfte Anwendungen
| Erfolgreiche Detektion in WB | A549-Zellen, HCT 116-Zellen, HeLa-Zellen, HepG2-Zellen, HUVEC-Zellen, MCF-7-Zellen, THP-1-Zellen, U-87 MG-Zellen |
| Erfolgreiche IP | MCF-7-Zellen |
| Erfolgreiche Detektion in IF/ICC | MCF-7-Zellen |
Empfohlene Verdünnung
| Anwendung | Verdünnung |
|---|---|
| Western Blot (WB) | WB : 1:500-1:3000 |
| Immunpräzipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunfluoreszenz (IF)/ICC | IF/ICC : 1:1000-1:4000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Veröffentlichte Anwendungen
| WB | See 2 publications below |
Produktinformation
82669-2-RR bindet in WB, IF/ICC, IP, ELISA P21 und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| In Publikationen genannte Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | P21 fusion protein Ag0368 |
| Vollständiger Name | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
| Berechnetes Molekulargewicht | 18 kDa |
| Beobachtetes Molekulargewicht | 21 kDa |
| GenBank-Zugangsnummer | BC000275 |
| Gene symbol | p21 |
| Gene ID (NCBI) | 1026 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS with 0.02% sodium azide and 50% glycerol |
| Lagerungsbedingungen | Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
CDKN1A (p21, CIP1, WAF1) is a cyclin-dependent kinase inhibitor. CDKN1A binds to and inhibits the activity of cyclin-CDK2 or -CDK4 complexes, and thus functions as a regulator of cell cycle progression at the G1 phase. The expression of CDKN1A is induced by wild-type but not mutant p53 protein, through which CDKN1A mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. CDKN1A can interact with proliferating cell nuclear antigen (PCNA), and plays a regulatory role in S phase DNA replication and DNA damage repair. CDKN1A was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of CDK2, and may be instrumental in the execution of apoptosis following caspase activation. Two alternatively spliced variants, which encode an identical protein, have been reported.
Protokolle
| PRODUKTSPEZIFISCHE PROTOKOLLE | |
|---|---|
| WB protocol for P21 antibody 82669-2-RR | Protokoll herunterladen |
| IF protocol for P21 antibody 82669-2-RR | Protokoll herunterladen |
| IP protocol for P21 antibody 82669-2-RR | Protokoll herunterladen |
| STANDARD-PROTOKOLLE | |
|---|---|
| Klicken Sie hier, um unsere Standardprotokolle anzuzeigen |
Publikationen
| Species | Application | Title |
|---|---|---|
J Biol Chem The P53-P21-RB1 pathway promotes BRD4 degradation in liver cancer through USP1 |





